Advertisement
Australia markets closed

  • ALL ORDS

    7,897.50
    +48.10 (+0.61%)
     

  • ASX 200

    7,629.00
    +42.00 (+0.55%)
     

  • AUD/USD

    0.6612
    +0.0040 (+0.61%)
     

  • OIL

    77.99
    -0.96 (-1.22%)
     

  • GOLD

    2,310.10
    +0.50 (+0.02%)
     

  • Bitcoin AUD

    96,461.20
    +2,887.23 (+3.09%)
     

  • CMC Crypto 200

    1,359.39
    +82.41 (+6.45%)
     

  • AUD/EUR

    0.6140
    +0.0020 (+0.33%)
     

  • AUD/NZD

    1.0992
    -0.0017 (-0.16%)
     

  • NZX 50

    11,938.08
    +64.04 (+0.54%)
     

  • NASDAQ

    17,890.79
    +349.25 (+1.99%)
     

  • FTSE

    8,213.49
    +41.34 (+0.51%)
     

  • Dow Jones

    38,675.68
    +450.02 (+1.18%)
     

  • DAX

    18,001.60
    +105.10 (+0.59%)
     

  • Hang Seng

    18,475.92
    +268.79 (+1.48%)
     

  • NIKKEI 225

    38,236.07
    -37.98 (-0.10%)
     

Here's What Key Metrics Tell Us About Encompass Health (EHC) Q1 Earnings

Zacks Equity Research
·2-min read

Encompass Health (EHC) reported $1.32 billion in revenue for the quarter ended March 2024, representing a year-over-year increase of 13.4%. EPS of $1.12 for the same period compares to $0.88 a year ago.

The reported revenue compares to the Zacks Consensus Estimate of $1.27 billion, representing a surprise of +3.60%. The company delivered an EPS surprise of +20.43%, with the consensus EPS estimate being $0.93.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

ADVERTISEMENT

Here is how Encompass Health performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

  • Net patient revenue per discharge: $20,990 compared to the $20,895.64 average estimate based on two analysts.

  • Total Discharges: 61,111 versus the two-analyst average estimate of 59,601.

  • Revenues- Inpatient Rehabilitation: $1.28 billion versus $1.25 billion estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +13.1% change.

  • Revenues- Outpatient and other: $33.30 million versus $27.56 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +27.1% change.

View all Key Company Metrics for Encompass Health here>>>

Shares of Encompass Health have returned +7.5% over the past month versus the Zacks S&P 500 composite's -3% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Encompass Health Corporation (EHC) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research